Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;42(21):2060-2068.
doi: 10.1093/eurheartj/ehab060.

Long-term outcomes in young patients with atrioventricular block of unknown aetiology

Affiliations

Long-term outcomes in young patients with atrioventricular block of unknown aetiology

Johnni Resdal Dideriksen et al. Eur Heart J. .

Erratum in

Abstract

Aims: Atrioventricular block (AVB) of unknown aetiology is rare in the young, and outcome in these patients is unknown. We aimed to assess long-term morbidity and mortality in young patients with AVB of unknown aetiology.

Methods and results: We identified all Danish patients younger than 50 years receiving a first pacemaker due to AVB between January 1996 and December 2015. By reviewing medical records, we included patients with AVB of unknown aetiology. A matched control cohort was established. Follow-up was performed using national registries. The primary outcome was a composite endpoint consisting of death, heart failure hospitalization, ventricular tachyarrhythmia, and cardiac arrest with successful resuscitation. We included 517 patients, and 5170 controls. Median age at first pacemaker implantation was 41.3 years [interquartile range (IQR) 32.7-46.2 years]. After a median follow-up of 9.8 years (IQR 5.7-14.5 years), the primary endpoint had occurred in 14.9% of patients and 3.2% of controls [hazard ratio (HR) 3.8; 95% confidence interval (CI) 2.9-5.1; P < 0.001]. Patients with persistent AVB at time of diagnosis had a higher risk of the primary endpoint (HR 10.6; 95% CI 5.7-20.0; P < 0.001), and risk was highest early in the follow-up period (HR 6.8; 95% CI 4.6-10.0; P < 0.001, during 0-5 years of follow-up).

Conclusion: Atrioventricular block of unknown aetiology presenting before the age of 50 years and treated with pacemaker implantation was associated with a three- to four-fold higher rate of the composite endpoint of death or hospitalization for heart failure, ventricular tachyarrhythmia, or cardiac arrest with successful resuscitation. Patients with persistent AVB were at higher risk. These findings warrant improved follow-up strategies for young patients with AVB of unknown aetiology.

Keywords: Atrioventricular block; Follow-up; Long-term outcomes; Pacemaker implantation; Unknown aetiology; Young.

PubMed Disclaimer

Figures

None
Atrioventricular block of unknown aetiology presenting before the age of 50 years and treated with pacemaker implantation was associated with a three- to four-fold higher rate of the composite endpoint of death or hospitalization for heart failure, ventricular tachyarrhythmia, or cardiac arrest with successful resuscitation. CI, confidence interval.
Figure 1
Figure 1
Patient inclusion in the period from 1 January 1996 until 31 December 2015. aThe control cohort was matched for age and gender.
Figure 2
Figure 2
Cumulative incidence of the primary endpointa in patients <50 years when receiving their first pacemaker due to atrioventricular block compared with the general population.b CI, confidence interval. aComposite of death from any cause, heart failure hospitalization, ventricular tachyarrhythmia hospitalization, and cardiac arrest with successful resuscitation. bControls from the general population were matched 10:1 for age and gender. Dashed line represents median follow-up time.
Figure 3
Figure 3
Cumulative incidence of the primary endpointa in patientsb with persistent or intermittent atrioventricular block compared with the general population.c AV, atrioventricular; CI, confidence interval. aComposite of death from any cause, heart failure hospitalization, ventricular tachyarrhythmia hospitalization, and cardiac arrest with successful resuscitation. bPatients <50 years when receiving their first pacemaker due to atrioventricular block. cControls from the general population were matched 10:1 for age and gender. Dashed line represents median follow-up time.
Figure 4
Figure 4
Cumulative incidence of secondary endpoints among patientsa and the general population.b AV, atrioventricular; CI, confidence interval. aPatients <50 years when receiving their first pacemaker due to atrioventricular block. bControls from the general population were matched 10:1 for age and gender. Deaths were considered competing risk in the non-fatal endpoints. Non-cardiovascular deaths were considered competing risk in the cardiovascular death endpoint.

Comment in

Similar articles

Cited by

References

    1. Danish Pacemaker and ICD Register. Danish Pacemaker and ICD Register Annual report 2015. https://ssl.icddata.dk/download/Danish_Pacemaker_and_ICD_Register_Annual....
    1. Udo EO, van Hemel NM, Zuithoff NP, Doevendans PA, Moons KG. Prognosis of the bradycardia pacemaker recipient assessed at first implantation: a nationwide cohort study. Heart 2013;99:1573–1578. - PubMed
    1. Zoob M, Smith KS. The aetiology of complete heart-block. Br Med J 1963;2:1149–1153. - PMC - PubMed
    1. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis 1964;6:409–444. - PubMed
    1. Rudbeck-Resdal J, Christiansen MK, Johansen JB, Nielsen JC, Bundgaard H, Jensen HK. Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study. Europace 2019;21:1710–1716. - PMC - PubMed

Publication types